Rigel Pharmaceuticals Inc. (RIGL): Share Price, Stock Analysis, Annual Report | Value Research Get Rigel Pharmaceuticals Inc. (RIGL)'s stock analysis, price valuation, corporate actions, and financials from India's independent mutual fund research house.
info-circle
company-logo

Click to see a quick summary and important updates about this stock!Dismiss

  • Healthcare
  • Biotechnology & Pharma Research

Rigel Pharmaceuticals Inc. (RIGL)

NASDAQ: RIGL

  • Market Capitalisation info

    $266 Mln


  • 12 Month Earnings info

    $-85 Mln

  • Price to Earnings info

    --

$1.54

As on 12-Aug-2022 16:00 EDT

up-down-arrow $0.1410.00%

  • Prev Close info

    $1.40

  • Day's Openinfo

    $1.41

  • Today's Highinfo

    $1.57

  • Today's Lowinfo

    $1.41

  • Today's Volumeinfo

    3,294,944

Please wait...

Stock Performance

YTD
1 Month
3 Months
1 Year
3 Years
5 Years
10 Years
Rigel Pharmaceuticals (RIGL)
-41.89 26.23 -17.65 -61.69 -10.39 -6.71 -16.78
S&P BSE Sensex
2.08 9.32 9.94 9.05 16.53 13.76 12.97
S&P Small-Cap 600
-8.13 14.13 12.23 -5.78 11.43 9.16 11.05
As on 12-Aug-2022
2021
2020
2019
2018
2017
2016
2015
Rigel Pharmaceuticals (RIGL)
-24.29 63.55 -6.96 -40.55 63.03 -21.45 33.48
S&P Small-Cap 600
25.27 9.57 20.86 -9.70 11.73 24.74 -3.36
S&P BSE Sensex
21.99 15.75 14.38 5.87 27.91 1.95 -5.03

Valuation

Stock
Peer Median

Growth & Efficiency

Stock
Peer Median

Solvency

Is there a threat to this company's solvency in the future?

Financial Manipulation

Can creative accounting be detected through the financial numbers?

Peer Comparison

search
search
search
search
    Please wait...

    Valuation Chart

      Please wait...
        Please wait...

        Financials

        Please wait...
        Please wait...
        Please wait...

        Shareholding Pattern

        Other Details

        Pres, CEO & Director

        Mr. Raul R. Rodriguez

        Exec. VP & CFO

        Mr. Dean L. Schorno CPA

        Headquarters

        South San Francisco, CA
        Edit edit
        Please wait...
        Please wait...

        Key Facts

        • Market cap info

          $266.17 Mln

        • Revenue (TTM) info

          $88.51 Mln

        • Earnings (TTM) info

          $-84.53 Mln

        • Cash info

          $89.17 Mln

        • Total Debt info

          $35.65 Mln

        • Insider's Holding

          1.20%

        • Liquidity info

          Low

        • 52 Week range info

          $0.65 - 4.24

        • Shares outstanding info

          172,836,000

        • 10 Years Aggregate:

          CFO: $-564.51 Mln

          EBITDA: $-636.63 Mln

          Net Profit: $-662.48 Mln

        About The Company

        • Business

          Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases.

        • IPO Date

          29-Nov-2000

        • Pres, CEO & Director

          Mr. Raul R. Rodriguez

        • Exec. VP & CFO

          Mr. Dean L. Schorno CPA

        • Listing info

          NASDAQ: RIGL

        • Country

          United States

        • Headquarters info

          South San Francisco, CA

        • Website info

          https://www.rigel.com